Oyster Point Pharma, Inc. Operating Income
Oyster Point Pharma, Inc. reported Operating Income of -$33.91 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2022-11-10
- Oyster Point Pharma, Inc. operating income (loss) for the quarter ending 2022-09-30 was -$33.91M.
- Oyster Point Pharma, Inc. operating income (loss) for the quarter ending 2022-06-30 was -$43.39M.
- Oyster Point Pharma, Inc. operating income (loss) for the quarter ending 2022-03-31 was -$42.21M.
- Oyster Point Pharma, Inc. operating income (loss) for the quarter ending 2021-12-31 was -$38.94M.
- Oyster Point Pharma, Inc. operating income (loss) for fiscal 2021 was -$96.66M.
- Oyster Point Pharma, Inc. operating income (loss) for fiscal 2020 was -$70.99M.
- Oyster Point Pharma, Inc. operating income (loss) for fiscal 2019 was -$47.30M.
- Oyster Point Pharma, Inc. operating income (loss) for fiscal 2018 was -$16.74M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2022-09-30 | -$33.91M 10-Q · filed 2022-11-10 | -$77.30M derived: sum of 2 quarters · filed 2022-11-10 | -$119.51M 10-Q · filed 2022-11-10 | -$158.45M derived: sum of 4 quarters · filed 2022-11-10 |
| 2022-06-30 | -$43.39M 10-Q · filed 2022-08-11 | -$85.60M 10-Q · filed 2022-08-11 | -$124.54M derived: sum of 3 quarters · filed 2022-08-11 | -$141.31M derived: sum of 4 quarters · filed 2022-11-10 |
| 2022-03-31 | -$42.21M 10-Q · filed 2022-05-05 | -$81.15M derived: sum of 2 quarters · filed 2022-05-05 | -$97.92M derived: sum of 3 quarters · filed 2022-11-10 | -$119.95M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-12-31 | -$38.94M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$55.71M derived: sum of 2 quarters · filed 2022-11-10 | -$77.73M derived: sum of 3 quarters · filed 2022-11-10 | -$96.66M 10-K · filed 2022-02-24 |
| 2021-09-30 | -$16.77M 10-Q · filed 2022-11-10 | -$38.79M derived: sum of 2 quarters · filed 2022-11-10 | -$57.71M 10-Q · filed 2022-11-10 | -$79.96M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$22.03M 10-Q · filed 2022-08-11 | -$40.95M 10-Q · filed 2022-08-11 | -$63.19M derived: sum of 3 quarters · filed 2022-08-11 | -$79.51M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$18.92M 10-Q · filed 2022-05-05 | -$41.16M derived: sum of 2 quarters · filed 2022-05-05 | -$57.49M derived: sum of 3 quarters · filed 2022-05-05 | -$72.98M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | -$22.24M 10-K · filed 2021-02-18 | -$38.57M derived: sum of 2 quarters · filed 2021-11-04 | -$54.06M derived: sum of 3 quarters · filed 2021-11-04 | -$70.99M 10-K · filed 2022-02-24 |
| 2020-09-30 | -$16.32M 10-Q · filed 2021-11-04 | -$31.82M derived: sum of 2 quarters · filed 2021-11-04 | -$48.74M 10-Q · filed 2021-11-04 | -$68.91M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | -$15.49M 10-Q · filed 2021-08-05 | -$32.42M 10-Q · filed 2021-08-05 | -$52.58M derived: sum of 3 quarters · filed 2021-08-05 | -$64.48M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | -$16.93M 10-Q · filed 2021-05-06 | -$37.09M derived: sum of 2 quarters · filed 2021-05-06 | -$48.99M derived: sum of 3 quarters · filed 2021-05-06 | -$60.22M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | -$20.16M 10-K · filed 2021-02-18 | -$32.06M derived: sum of 2 quarters · filed 2021-02-18 | -$43.29M derived: sum of 3 quarters · filed 2021-02-18 | -$47.30M 10-K · filed 2021-02-18 |
| 2019-09-30 | -$11.90M 10-K · filed 2021-02-18 | -$23.13M derived: sum of 2 quarters · filed 2021-02-18 | -$27.14M 10-Q · filed 2020-11-05 | -$31.19M derived: sum of 4 quarters · filed 2021-02-18 |
| 2019-06-30 | -$11.23M 10-K · filed 2021-02-18 | -$15.24M 10-Q · filed 2020-08-05 | -$19.29M derived: sum of 3 quarters · filed 2021-02-18 | -$25.98M derived: sum of 4 quarters · filed 2021-02-18 |
| 2019-03-31 | -$4.01M 10-K · filed 2021-02-18 | -$8.06M derived: sum of 2 quarters · filed 2021-02-18 | -$14.75M derived: sum of 3 quarters · filed 2021-02-18 | -$17.75M derived: sum of 4 quarters · filed 2021-02-18 |
| 2018-12-31 | -$4.05M 10-K · filed 2020-02-27 | -$10.74M derived: sum of 2 quarters · filed 2020-02-27 | -$13.74M derived: sum of 3 quarters · filed 2020-02-27 | -$16.74M 10-K · filed 2020-02-27 |
| 2018-09-30 | -$6.69M 10-K · filed 2020-02-27 | -$9.69M derived: sum of 2 quarters · filed 2020-02-27 | -$12.69M 10-Q · filed 2019-12-03 | |
| 2018-06-30 | -$3.00M 10-K · filed 2020-02-27 | -$6.00M derived: sum of 2 quarters · filed 2020-02-27 | ||
| 2018-03-31 | -$3.00M 10-K · filed 2020-02-27 |